Ashley Shoemaker Archives
New insights into hypothalamic obesity
Feb. 10, 2022—A common Type 2 diabetes treatment being tested for hypothalamic obesity had unexpected results on weight loss and total energy expenditure, Vanderbilt researchers report.
New treatment for a rare obesity
Nov. 3, 2020—Diabetes drugs known as GLP-1 receptor agonists, such as exenatide (Byetta), are a promising and safe treatment for a rare form of obesity.
VUMC researchers set for Cutting-Edge Discovery Lecture
Nov. 14, 2019—Antiviral immunity, obesity and pulmonary fibrosis will be discussed by three Vanderbilt University researchers during a Cutting-Edge Discovery Lecture on Nov. 21. The lecture will begin at 4 p.m. in 208 Light Hall.
Kropski, Shoemaker honored by Doris Duke Foundation
Aug. 9, 2018—Two early-career physician-scientists at Vanderbilt University Medical Center are among 18 recipients of 2018 Clinical Scientist Development Awards announced July 31 by the Doris Duke Charitable Foundation.
Cognition in rare hormonal disorder
Feb. 13, 2018—Vanderbilt investigators have conducted the first systematic evaluation of cognitive function in children with a rare genetic disorder.
Vanderbilt Pre-Diabetes Clinic tackles type 2 diabetes in children
Jun. 22, 2017—In Middle Tennessee, where roughly one-third of children are overweight or obese, the risk of developing pediatric type 2 diabetes is high and the consequences can be serious.